삼성바이오, 국민연금 반대에도 ‘잡음없이’ 주총 원안 승인

Shareholders voted in favor of Samsung BioLogics' key proposals despite the National Pension Service's opposition, citing the firm's alleged accounting fraud.
At the company's annual shareholders' meeting, shareholders approved the financial statement and the appointment of inside and outside executives.
Samsung BioLogics' president vowed to continue winning more contracts for biopharmaceutical research and production.